A control survey technique using a laser tracker and a digital level was introduced to the KEK e−/e+ injector linac in 2020. Control surveys are continuously demonstrated during the machine’s downtimes every summer. Analysis of the two-year data reproduces their trends in terms of the fiducial points on the beam line. In our paper, we report on systematic coordinates and their error distributions evaluated by a control survey, compare them with a numerical survey simulation, and discuss newly encountered issues.
KEK electron positron injector LINAC initiated the injection operation into Photon Factory (PF) light source in 1982. Since then for 39 years, it has served for multiple projects, namely, TRISTAN, PF-AR, KEKB, and SuperKEKB. Its total operation time has accumulated 200 thousand hours on May 7, 2020. We are extremely proud of the achievement following continuous efforts by our seniors. The construction of the injector LINAC started in 1978, and it was commissioned for PF with 2.5 GeV electron in 1982. In parallel, the positron generator linac was constructed for the TRISTAN collider project. The slow positron facility was also commissioned in 1992. After the KEKB asymmetric-energy collider project was commissioned in 1998 with direct energy injections, the techniques such as two-bunch acceleration and simultaneous injection were developed. As the soft structure design of the LINAC was too weak against the great east Japan earthquake, it took three years to recover. Then the construction and commissioning for the SuperKEKB project went on, and the simultaneous top-up injection into four storage rings contributes to the both elementary particle physics and photon science.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.